Patents Assigned to STREAM BIOMEDICAL, INC.
  • USE OF PERLECAN AND FRAGMENTS THEREOF TO REDUCE THE RISK OF DEATH IN STROKE PATIENTS
    Publication number: 20230293632
    Abstract: The present disclosure is directed to the use of perlecan compositions to reduce the risk of mortality in subjects due to neurological injury such as stroke, including large vessel occlusion, and traumatic brain injury. The disclosure is also directed to the use of perlecan compositions to reduce mortality in stroke patients treated with tPA.
    Type: Application
    Filed: July 26, 2021
    Publication date: September 21, 2023
    Applicant: STREAM BIOMEDICAL, INC.
    Inventors: Huston Davis ADKISSON, Bryan Lloyd CLOSSEN, Gary B. GAGE